NEW DELHI: The Drug Controller General of India (DCGI) has found

The principle of attached growth process has been incorporated in this research study for the treatment of pharmaceutical wastewater. An investigation has been made using laboratory scale model upflow anaerobic filter (UAF) using polyurethane foam as packing medium to evaluate its performance in treating pharmaceutical wastewater under the influence of various operating conditions.

Maharashtra acquires land by force NATHNAGAR village, about 20 km from Aurangabad, lost its crop before harvest. On December 3, officials of the Maharashtra Industrial Development Corporation went there to take possession of about 50 hectares that has been earmarked for a pharmaceutical special economic zone being set up by Ajanta Process Engineering Company. But due to stiff

Vitamin C tablets scarce, costlier ALREADY in short supply, vitamin C has become costlier. The National Pharmaceutical Pricing Authority increased the price of seven essential drugs on November 25. The authority controls the price of 74 drugs classified essential. The pharmaceutical industry had approached the pricing authority to revise the prices of some essential drugs since

Pb Jayakumar & Joe C Mathew / Mumbai/new Delhi December 06, 2008, 0:27 IST

Roche Scientific Company (India) Ltd, the local arm of Swiss drug maker F Hoffman-La Roche, will launch a new-generation rheumatoid arthritis drug, Actemra, in India, even as it awaits approvals from US and European drug regulators.

Joe C Mathew & P B Jayakumar / New Delhi/mumbai December 03, 2008, 0:48 IST

First time, an Indian court revisits a patent office order.

Clinical trials sustain Ahmedabad

This paper presents a comprehensive overview of India

commonly used medicines like Becosule, Dexorange and Corex figure in the list of medicines that the government wanted removed from the market last year. But these medicines, classified under fixed dose combinations, or fdcs, continue to be sold. The pharma industry is reviewing the list currently. Health activists fear that companies may use this opportunity to their advantage. The Drug

Big pharma has big incentives, including cost savings and more powerful studies, to launch trials in developing countries. But can companies avoid the ethical potholes?

Pages